Last reviewed · How we verify
NCT05847543: Poobiome
Building an AI to Infer/Predict an Estimated Stool Microbiome Profile
trial testing Stool diaper data and sample collection in Healthy in 440 participants. Completed in 22 December 2024.
28 September 2024
Quick facts
| Lead sponsor | Danone Asia Pacific Holdings Pte, Ltd. |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 440 |
| Start date | 21 March 2023 |
| Primary completion | 28 September 2024 |
| Estimated completion | 22 December 2024 |
| Sites | 4 locations across Singapore, Thailand, Malaysia |
Drugs / interventions tested
- Stool diaper data and sample collection
Conditions studied
- Healthy — all drugs for Healthy →
Sponsor
Danone Asia Pacific Holdings Pte, Ltd.
Who can join
Adults 0 Months to 18 Months, any sex, with Healthy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a study to collect data to build, evaluate and validate (test) a tool to infer/predict an estimated microbiome (community of microorganisms such as bacteria, fungi and viruses that exists in a particular environment) profile. The study will take place at several hospitals/clinics across Singapore, Malaysia, and Thailand.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05847543
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Healthy
Currently open trials in the same condition.
- NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
- NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
- NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
- NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
- NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting
Other Danone Asia Pacific Holdings Pte, Ltd. trials
Trials by the same sponsor.
- NCT07186205 — A Study to Collect Data to Build Artificial Intelligence Derived Algorithms for Estimating Risk of Iron Deficiency and A · completed
- NCT06577727 — A Study to Collect Data to Build Artificial Intelligence Derived Algorithms for Estimating Iron Status of Children · completed
- NCT06578338 — Assessing a Height Artificial Intelligence Algorithm to Estimate Height of Children · completed
- NCT06578351 — TRacking Atopic Dermatitis Infants and Their Microbiome (TRAM) · completed
- NCT05079776 — Assessing a Length Artificial Intelligence Algorithm to Estimate Length of Children · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05847543 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Danone Asia Pacific Holdings Pte, Ltd.
- Last refreshed: 6 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05847543.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing